Implementation Plan for the Memorandum of Understanding Regarding the Sharing and Exchange of Information About Therapeutic Products Between the Food and Drug Administration Department of Health and Human Services of the United States of America and Health Products and Food Branch, Health Canada of Canada, 944-950 [06-113]

Download as PDF 944 Federal Register / Vol. 71, No. 4 / Friday, January 6, 2006 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [FDA 225–05–8007] Implementation Plan for the Memorandum of Understanding Regarding the Sharing and Exchange of Information About Therapeutic Products Between the Food and Drug Administration Department of Health and Human Services of the United States of America and Health Products and Food Branch, Health Canada of Canada AGENCY: Food and Drug Administration, HHS. ACTION: Notice. cprice-sewell on PROD1PC66 with NOTICES SUMMARY: The Food and Drug Administration (FDA) is providing notice of an Implementation Plan VerDate Aug<31>2005 15:23 Jan 05, 2006 Jkt 208001 (Implementation Plan) for the Memorandum of Understanding (MOU) Regarding the Sharing and Exchange of Information About Therapeutic Products Between the Food and Drug Administration Department of Health and Human Services of the United States of America and the Health Products and Food Branch, Health Canada of Canada. The purpose of the Implementation Plan is to establish the following: A governance structure for directing and monitoring the implementation of the MOU; clear process by which each party will undertake the exchange of otherwise not public information; and the process for setting and monitoring mutually agreed upon annual priorities for cooperation. DATES: The Implementation Plan became effective December 1, 2005. FOR FURTHER INFORMATION CONTACT: Matthew E. Eckel, Office of PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 International Programs, (HFG–1), 5600 Fishers Lane, Rockville MD, 20857, 301–827–4480, FAX: 301–480–0716. In accordance with 21 CFR 20.108(a) and (c), which states that all written agreements and understandings signed by FDA and other departments, agencies, and organizations shall be published in the Federal Register, except those agreements and memoranda of understanding between FDA and State or local government agencies that are cooperative worksharing agreements, the agency is publishing notice of this Implementation Plan. SUPPLEMENTARY INFORMATION: Dated: December 30, 2005. Jeffrey Shuren, Assistant Commissioner for Policy. BILLING CODE 4160–01–S E:\FR\FM\06JAN1.SGM 06JAN1 VerDate Aug<31>2005 15:23 Jan 05, 2006 Jkt 208001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4725 E:\FR\FM\06JAN1.SGM 06JAN1 945 EN06JA06.366</GPH> cprice-sewell on PROD1PC66 with NOTICES Federal Register / Vol. 71, No. 4 / Friday, January 6, 2006 / Notices VerDate Aug<31>2005 Federal Register / Vol. 71, No. 4 / Friday, January 6, 2006 / Notices 15:23 Jan 05, 2006 Jkt 208001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4725 E:\FR\FM\06JAN1.SGM 06JAN1 EN06JA06.367</GPH> cprice-sewell on PROD1PC66 with NOTICES 946 VerDate Aug<31>2005 15:23 Jan 05, 2006 Jkt 208001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4725 E:\FR\FM\06JAN1.SGM 06JAN1 947 EN06JA06.368</GPH> cprice-sewell on PROD1PC66 with NOTICES Federal Register / Vol. 71, No. 4 / Friday, January 6, 2006 / Notices VerDate Aug<31>2005 Federal Register / Vol. 71, No. 4 / Friday, January 6, 2006 / Notices 15:23 Jan 05, 2006 Jkt 208001 PO 00000 Frm 00045 Fmt 4703 Sfmt 4725 E:\FR\FM\06JAN1.SGM 06JAN1 EN06JA06.369</GPH> cprice-sewell on PROD1PC66 with NOTICES 948 VerDate Aug<31>2005 15:23 Jan 05, 2006 Jkt 208001 PO 00000 Frm 00046 Fmt 4703 Sfmt 4725 E:\FR\FM\06JAN1.SGM 06JAN1 949 EN06JA06.370</GPH> cprice-sewell on PROD1PC66 with NOTICES Federal Register / Vol. 71, No. 4 / Friday, January 6, 2006 / Notices 950 Federal Register / Vol. 71, No. 4 / Friday, January 6, 2006 / Notices BILLING CODE 4160–01–C DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration cprice-sewell on PROD1PC66 with NOTICES Center for Substance Abuse Treatment; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given of the meeting of the Center for Substance Abuse Treatment (CSAT) National Advisory Council in February 2006. The meeting is open and will include discussion of the Center’s policy issues, current administrative, legislative, and program developments. Attendance by the public will be limited to space available. Public comments are welcome. Please communicate with the individual listed below as contact to make arrangements to comment or to request special accommodations for persons with disabilities. Substantive program information and a roster of Council members may be obtained by accessing the SAMHSA Advisory Council Web site (https:// www.samhsa.gov) after the meeting or by communicating with the contact whose name and telephone number are listed below. The transcript for the open session will also be available on the VerDate Aug<31>2005 15:23 Jan 05, 2006 Jkt 208001 SAMHSA Advisory Council Web site by February 27, 2005. Committee Name: Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment National Advisory Council. Meeting Dates: February 2—9 a.m.–5 p.m.; February 3—9 a.m.–1 p.m. Place: 1 Choke Cherry Road, Sugar Loaf and Seneca Conference Rooms, Rockville, Maryland 20857. Type: Open: February 2—9 a.m.–5 p.m.; Open: February 3—9 a.m.–1 p.m. Contact: Cynthia Graham, M.S., Executive Secretary, SAMHSA/CSAT National Advisory Council, 1 Choke Cherry Road, Room 5–1036, Rockville, MD 20857, Telephone: (240) 276–1692, Fax: (240) 276–1690, E-mail: cynthia.graham@samhsa.hhs.gov. Dated: December 28, 2005. Toian Vaughn, Committee Management Officer, Substance Abuse and Mental Health Services Administration. [FR Doc. E6–7 Filed 1–5–06; 8:45 am] BILLING CODE 4162–20–P PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–5045–N–01] Federal Property Suitable as Facilities to Assist the Homeless Office of the Assistant Secretary for Community Planning and Development, HUD. ACTION: Notice. AGENCY: SUMMARY: This Notice identifies unutilized, underutilized, excess, and surplus Federal property reviewed by HUD for suitability for possible use to assist the homeless. EFFECTIVE DATE: January 6, 2006. FOR FURTHER INFORMATION CONTACT: Kathy Ezzell, Department of Housing and Urban Development, Room 7262, 451 Seventh Street, SW., Washington, DC 20410; telephone (202) 708–1234; TTY number for the hearing- and speech-impaired (202) 708–2565, (these telephone numbers are not toll-free), or call the toll-free Title V information line at 1–800–927–7588. SUPPLEMENTARY INFORMATION: In accordance with the December 12, 1988 court order in National Coalition for the Homeless v. Veterans Administration, No. 88–2503–OG (D.D.C.), HUD publishes a Notice, on a weekly basis, identifying unutilized, underutilized, excess and surplus Federal buildings and real property that HUD has reviewed for suitability for use to assist E:\FR\FM\06JAN1.SGM 06JAN1 EN06JA06.371</GPH> [FR Doc. 06–113 Filed 1–5–06; 8:45 am]

Agencies

[Federal Register Volume 71, Number 4 (Friday, January 6, 2006)]
[Notices]
[Pages 944-950]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-113]



[[Page 944]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[FDA 225-05-8007]


Implementation Plan for the Memorandum of Understanding Regarding 
the Sharing and Exchange of Information About Therapeutic Products 
Between the Food and Drug Administration Department of Health and Human 
Services of the United States of America and Health Products and Food 
Branch, Health Canada of Canada

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is providing notice of 
an Implementation Plan (Implementation Plan) for the Memorandum of 
Understanding (MOU) Regarding the Sharing and Exchange of Information 
About Therapeutic Products Between the Food and Drug Administration 
Department of Health and Human Services of the United States of America 
and the Health Products and Food Branch, Health Canada of Canada. The 
purpose of the Implementation Plan is to establish the following: A 
governance structure for directing and monitoring the implementation of 
the MOU; clear process by which each party will undertake the exchange 
of otherwise not public information; and the process for setting and 
monitoring mutually agreed upon annual priorities for cooperation.

DATES: The Implementation Plan became effective December 1, 2005.

FOR FURTHER INFORMATION CONTACT: Matthew E. Eckel, Office of 
International Programs, (HFG-1), 5600 Fishers Lane, Rockville MD, 
20857, 301-827-4480, FAX: 301-480-0716.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(a) and (c), 
which states that all written agreements and understandings signed by 
FDA and other departments, agencies, and organizations shall be 
published in the Federal Register, except those agreements and 
memoranda of understanding between FDA and State or local government 
agencies that are cooperative work-sharing agreements, the agency is 
publishing notice of this Implementation Plan.

    Dated: December 30, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
BILLING CODE 4160-01-S

[[Page 945]]

[GRAPHIC] [TIFF OMITTED] TN06JA06.366


[[Page 946]]


[GRAPHIC] [TIFF OMITTED] TN06JA06.367


[[Page 947]]


[GRAPHIC] [TIFF OMITTED] TN06JA06.368


[[Page 948]]


[GRAPHIC] [TIFF OMITTED] TN06JA06.369


[[Page 949]]


[GRAPHIC] [TIFF OMITTED] TN06JA06.370


[[Page 950]]


[GRAPHIC] [TIFF OMITTED] TN06JA06.371

[FR Doc. 06-113 Filed 1-5-06; 8:45 am]
BILLING CODE 4160-01-C
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.